PURPLE BIOTECH LTD. Equity And Liabilities
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2026-03-19
- 2025-12-31: Equity And Liabilities $17.57M.
- 2024-12-31: Equity And Liabilities $37.04M.
- 2023-12-31: Equity And Liabilities $44.30M.
- 2022-12-31: Equity And Liabilities $54.62M.
| Period end | Equity And Liabilities |
|---|---|
| 2025-12-31 | $17.57M 20-F · filed 2026-03-19 |
| 2024-12-31 | $37.04M 20-F · filed 2026-03-19 |
| 2023-12-31 | $44.30M 20-F · filed 2025-03-10 |
| 2022-12-31 | $54.62M 20-F · filed 2024-03-05 |
| 2021-12-31 | $70.20M 20-F · filed 2023-03-03 |
| 2020-12-31 | $83.80M 20-F · filed 2022-03-09 |
| 2019-12-31 | $14.72M 20-F · filed 2021-03-16 |
| 2019-06-30 | $17.19M 6-K · filed 2019-08-26 |
| 2018-12-31 | $14.72M 20-F · filed 2020-03-23 |
| 2018-06-30 | $18.38M 6-K · filed 2018-09-17 |
| 2017-12-31 | $14.18M 20-F · filed 2019-03-26 |
| 2016-12-31 | $14.91M 20-F · filed 2018-03-05 |